Ovesse (Estriol)

Ovesse contains estradiol, an estrogen that acts on the hormonal pathway to relieve estrogen‑deficient conditions.

• Menopause: alleviates vasomotor symptoms such as hot flashes and night sweats.
• Hypo‑estrogenism post‑menopause: supports bone health and reduces risk of osteoporosis.
• Surgical menopause: replaces estrogen after oophorectomy to manage symptoms.
• Primary ovarian insufficiency: provides estrogen to aid development of secondary sexual characteristics.
• Hormone‑responsive breast cancer adjunct: used in specific protocols under specialist supervision.
• Transgender hormone therapy: contributes to feminizing hormone regimens under medical guidance.

• Estradiol binds to intracellular estrogen receptors (ERα and ER β) and modulates gene transcription. This receptor activation influences the growth and function of estrogen‑dependent tissues, regulating the menstrual cycle, bone remodeling, lipid metabolism, and vasomotor stability. The drug’s systemic effects arise from its ability to restore physiological estrogen levels in deficient states.

Estradiol therapy may produce a range of adverse reactions, from mild to serious.

Common Side Effects

• Nausea: mild, transient gastrointestinal upset.
• Breast tenderness: localized discomfort or swelling.
• Headache: mild to moderate intensity.
• Fluid retention: mild peripheral edema.
• Mood changes: irritability or mild depressive symptoms.
• Vaginal spotting: light bleeding between periods.

Serious or Rare Side Effects

• Thromboembolic events: deep‑vein thrombosis or pulmonary embolism.
• Stroke: cerebrovascular accident, particularly in high‑risk patients.
• Hepatotoxicity: abnormal liver function tests or hepatitis.
• Endometrial hyperplasia: abnormal uterine lining growth.
• Gallbladder disease: gallstones or cholecystitis.
• Breast cancer: potential increased risk with long‑term use.

When prescribing estradiol, clinicians should consider several safety measures.

• Cardiovascular risk assessment: evaluate history of clotting, stroke, or heart disease.
• Cancer screening: ensure breast and endometrial cancer surveillance before initiation.
• Liver function monitoring: check baseline hepatic enzymes and repeat as needed.
• Hormone‑dependent conditions: avoid in active estrogen‑sensitive malignancies.
• Pregnancy and lactation: contraindicated in women who are pregnant or breastfeeding.
• Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Estradiol can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of thrombosis.
• Certain antiretrovirals (e.g., protease inhibitors): may raise estradiol levels.
• Aromatase inhibitors: counteract estrogenic effects.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., carbamazepine, phenytoin): may reduce estradiol concentrations.
• Thyroid hormones: may require dose adjustment of levothyroxine.
• SSRIs/SNRIs: can worsen breast tenderness and fluid retention.